Philip Morris International Inc. (PM) Q2 FY2026 Financial Statements: Net revenues $11.19B, Net income $2.82B
More for Philip Morris International: Company index · 10-K and 10-Q summary · 8-K filings and events
PeriodQ2 FY2026
Published
Philip Morris International reported $11.19 billion in net revenues for Q2 FY2026, the quarter ended June 30, 2026, up 10.4% from a year earlier, with operating income of $4.53 billion, up 22.0%. Net income attributable to shareholders was $2.82 billion, down 7.3%, and diluted earnings per share fell to $1.80 from $1.95, held back by a non-cash impairment charge of $511 million against the company's equity investment in Canadian affiliate Rothmans, Benson & Hedges, by lower income from equity security investments and by a higher effective tax rate, all of which sit below the operating line. Smoke-free products accounted for $4.64 billion of the quarter's net revenues, up 11.6%.
| Metric | Amount | vs. year ago |
|---|---|---|
| Net revenues | $11,192,000,000 | up 10.4% |
| Net income | $2,817,000,000 | down 7.3% |
| Diluted EPS | $1.80 | down 7.7% |
| Operating income | $4,530,000,000 | up 22.0% |
| Smoke-free net revenues | $4,645,000,000 | up 11.6% |
| RBH impairment | $511,000,000 |
About this file
| Ticker | PM |
|---|---|
| CIK | 0001413329 |
| Company | Philip Morris International Inc. |
| Business type | industrial |
| Schema template | standard (consumer products manufacturer): net revenues, cost of sales, gross profit, operating income, net earnings, per-share data; balance sheet with cash, debt, assets and equity; cash flow with operating cash flow, capital expenditures and free cash flow. Segment net revenues and segment gross profit are added because segment gross profit is the profitability measure Philip Morris International now uses to manage its reportable segments. |
| Reporting currency | USD |
| Converted to USD | no |
| Units | actual dollars (not millions); share counts in actual shares; per-share amounts in dollars |
PM annual income statement, balance sheet and cash flow
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Fiscal year | 2025 | 2024 | 2023 |
| Label | FY2025 | FY2024 | FY2023 |
| Period start | 2025-01-01 | 2024-01-01 | 2023-01-01 |
| Period end | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Period type | fiscal year | fiscal year | fiscal year |
| Source accession | 0001628280-26-005939 | 0001628280-26-005939 | 0001628280-26-005939 |
| Income statement | |||
| Net revenue | 40,648,000,000 | 37,878,000,000 | 35,174,000,000 |
| Cost of sales | 13,366,000,000 | 13,329,000,000 | 12,893,000,000 |
| Gross profit | 27,282,000,000 | 24,549,000,000 | 22,281,000,000 |
| Marketing administration and research costs | 12,349,000,000 | 11,147,000,000 | 10,060,000,000 |
| Impairment of goodwill | 41,000,000 | 0 | 665,000,000 |
| Operating income | 14,892,000,000 | 13,402,000,000 | 11,556,000,000 |
| Interest expense net | 966,000,000 | 1,143,000,000 | 1,061,000,000 |
| Pension and other employee benefit costs | 46,000,000 | 60,000,000 | 45,000,000 |
| Earnings before income taxes | 13,880,000,000 | 12,199,000,000 | 10,450,000,000 |
| Provision for income taxes | 2,737,000,000 | 3,017,000,000 | 2,339,000,000 |
| Impairment related to rbh equity investment | 0 | 2,316,000,000 | 0 |
| Equity investments and securities income loss net | -705,000,000 | -637,000,000 | -157,000,000 |
| Net earnings including noncontrolling interests | 11,848,000,000 | 7,503,000,000 | 8,268,000,000 |
| Net earnings attributable to noncontrolling interests | 500,000,000 | 446,000,000 | 455,000,000 |
| Net income attributable to shareholders | 11,348,000,000 | 7,057,000,000 | 7,813,000,000 |
| Net income available to common stockholders | 11,316,000,000 | 7,034,000,000 | 7,791,000,000 |
| Basic EPS | 7.27 | 4.53 | 5.02 |
| Diluted EPS | 7.26 | 4.52 | 5.02 |
| Basic shares | 1,556,000,000 | 1,554,000,000 | 1,552,000,000 |
| Diluted shares | 1,558,000,000 | 1,556,000,000 | 1,553,000,000 |
| Balance sheet | |||
| Cash and cash equivalents | 4,872,000,000 | 4,216,000,000 | |
| Inventories | 11,478,000,000 | 9,453,000,000 | |
| Total current assets | 24,363,000,000 | 20,170,000,000 | |
| Goodwill | 17,264,000,000 | 16,600,000,000 | |
| Other intangible assets net | 10,884,000,000 | 11,327,000,000 | |
| Total assets | 69,185,000,000 | 61,784,000,000 | |
| Short term borrowings | 168,000,000 | 137,000,000 | |
| Current portion of long term debt | 3,533,000,000 | 3,392,000,000 | |
| Total current liabilities | 25,427,000,000 | 22,915,000,000 | |
| Long term debt | 45,134,000,000 | 42,166,000,000 | |
| Total liabilities | 77,213,000,000 | 71,654,000,000 | |
| Total pmi stockholders deficit | -9,994,000,000 | -11,750,000,000 | |
| Noncontrolling interests | 1,966,000,000 | 1,880,000,000 | |
| Total stockholders equity including noncontrolling interests | -8,028,000,000 | -9,870,000,000 | |
| Total debt | 48,835,000,000 | 45,695,000,000 | |
| Cash flow | |||
| Operating cash flow | 12,233,000,000 | 12,217,000,000 | 9,204,000,000 |
| Capital expenditures | -1,569,000,000 | -1,444,000,000 | -1,321,000,000 |
| Investing cash flow | -3,967,000,000 | -1,092,000,000 | -3,598,000,000 |
| Dividends paid | -8,624,000,000 | -8,197,000,000 | -7,964,000,000 |
| Financing cash flow | -8,132,000,000 | -9,481,000,000 | -5,582,000,000 |
| Free cash flow | 10,664,000,000 | 10,773,000,000 | 7,883,000,000 |
| Supplemental | |||
| Depreciation and amortization | 1,996,000,000 | 1,787,000,000 | 1,398,000,000 |
| Dividends declared per share | 5.64 | 5.3 | 5.14 |
| Excise taxes on products | 53,211,000,000 | 51,563,000,000 | 49,404,000,000 |
PM quarterly income statement, balance sheet and cash flow
| Q2 2026 | Q2 2025 | |
|---|---|---|
| Label | Q2 2026 | Q2 2025 |
| Fiscal year | 2026 | 2025 |
| Fiscal quarter | 2 | 2 |
| Period start | 2026-04-01 | 2025-04-01 |
| Period end | 2026-06-30 | 2025-06-30 |
| Period type | three months | three months |
| Source accession | 0001628280-26-049493 | 0001628280-26-049493 |
| Income statement | ||
| Net revenue | 11,192,000,000 | 10,140,000,000 |
| Cost of sales | 3,533,000,000 | 3,274,000,000 |
| Gross profit | 7,659,000,000 | 6,866,000,000 |
| Marketing administration and research costs | 2,981,000,000 | 2,988,000,000 |
| Impairment of goodwill | 0 | 41,000,000 |
| Corporate expenses and other | 148,000,000 | 125,000,000 |
| Operating income | 4,530,000,000 | 3,712,000,000 |
| Interest expense net | 243,000,000 | 277,000,000 |
| Pension and other employee benefit costs | -5,000,000 | 11,000,000 |
| Earnings before income taxes | 4,292,000,000 | 3,424,000,000 |
| Provision for income taxes | 955,000,000 | 652,000,000 |
| Impairment related to rbh equity investment | 511,000,000 | 0 |
| Equity investments and securities income loss net | -159,000,000 | -376,000,000 |
| Net earnings including noncontrolling interests | 2,985,000,000 | 3,148,000,000 |
| Net earnings attributable to noncontrolling interests | 168,000,000 | 109,000,000 |
| Net income attributable to shareholders | 2,817,000,000 | 3,039,000,000 |
| Basic EPS | 1.8 | 1.95 |
| Diluted EPS | 1.8 | 1.95 |
| Net income available to common stockholders | 2,810,000,000 | 3,031,000,000 |
| Basic shares | 1,559,000,000 | 1,557,000,000 |
| Diluted shares | 1,560,000,000 | 1,558,000,000 |
| Balance sheet | ||
| Cash and cash equivalents | 5,999,000,000 | |
| Inventories | 11,436,000,000 | |
| Total current assets | 26,006,000,000 | |
| Goodwill | 16,917,000,000 | |
| Other intangible assets net | 10,178,000,000 | |
| Total assets | 68,271,000,000 | |
| Short term borrowings | 3,341,000,000 | |
| Current portion of long term debt | 3,406,000,000 | |
| Total current liabilities | 26,542,000,000 | |
| Long term debt | 42,366,000,000 | |
| Total liabilities | 74,928,000,000 | |
| Total pmi stockholders deficit | -8,583,000,000 | |
| Noncontrolling interests | 1,926,000,000 | 1,954,000,000 |
| Total stockholders equity including noncontrolling interests | -6,657,000,000 | -10,012,000,000 |
| Total debt | 49,113,000,000 | |
| Supplemental | ||
| Depreciation and amortization | 513,000,000 | 490,000,000 |
| Dividends declared per share | 1.47 | 1.35 |
| Excise taxes on products | 14,973,000,000 | 13,272,000,000 |
| Segments | ||
| International smoke free | ||
| Net revenues | 3,877,000,000 | 3,395,000,000 |
| Cost of sales | -1,161,000,000 | -1,076,000,000 |
| Gross profit | 2,716,000,000 | 2,319,000,000 |
| International combustibles | ||
| Net revenues | 6,459,000,000 | 5,883,000,000 |
| Cost of sales | -2,071,000,000 | -1,947,000,000 |
| Gross profit | 4,388,000,000 | 3,936,000,000 |
| US | ||
| Net revenues | 856,000,000 | 862,000,000 |
| Cost of sales | -301,000,000 | -252,000,000 |
| Gross profit | 555,000,000 | 611,000,000 |
| Net revenue by product category | ||
| Total smoke free | 4,645,000,000 | 4,161,000,000 |
| Total combustible tobacco | 6,547,000,000 | 5,979,000,000 |
PM year-to-date income statement and cash flow
| Six months ended June 30, 2026 | |
|---|---|
| Label | Six months ended June 30, 2026 |
| Period start | 2026-01-01 |
| Period end | 2026-06-30 |
| Period type | six months |
| Source accession | 0001628280-26-049493 |
| Income statement | |
| Net revenue | 21,338,000,000 |
| Cost of sales | 6,774,000,000 |
| Gross profit | 14,564,000,000 |
| Marketing administration and research costs | 5,838,000,000 |
| Impairment of goodwill | 0 |
| Corporate expenses and other | 303,000,000 |
| Operating income | 8,423,000,000 |
| Interest expense net | 480,000,000 |
| Pension and other employee benefit costs | -10,000,000 |
| Earnings before income taxes | 7,953,000,000 |
| Provision for income taxes | 1,631,000,000 |
| Impairment related to rbh equity investment | 511,000,000 |
| Equity investments and securities income loss net | 244,000,000 |
| Net earnings including noncontrolling interests | 5,567,000,000 |
| Net earnings attributable to noncontrolling interests | 312,000,000 |
| Net income attributable to shareholders | 5,255,000,000 |
| Net income available to common stockholders | 5,241,000,000 |
| Basic EPS | 3.36 |
| Diluted EPS | 3.36 |
| Basic shares | 1,558,000,000 |
| Diluted shares | 1,560,000,000 |
| Cash flow | |
| Operating cash flow | 5,093,000,000 |
| Capital expenditures | -733,000,000 |
| Investing cash flow | 23,000,000 |
| Dividends paid | -4,604,000,000 |
| Financing cash flow | -3,879,000,000 |
| Free cash flow | 4,360,000,000 |
| Supplemental | |
| Depreciation and amortization | 1,023,000,000 |
| Dividends declared per share | 2.94 |
| Excise taxes on products | 27,826,000,000 |
| Segments | |
| International smoke free | |
| Net revenues | 7,713,000,000 |
| Cost of sales | -2,313,000,000 |
| Gross profit | 5,400,000,000 |
| International combustibles | |
| Net revenues | 12,147,000,000 |
| Cost of sales | -3,917,000,000 |
| Gross profit | 8,229,000,000 |
| US | |
| Net revenues | 1,478,000,000 |
| Cost of sales | -544,000,000 |
| Gross profit | 935,000,000 |
| Net revenue by product category | |
| Total smoke free | 9,024,000,000 |
| Total combustible tobacco | 12,314,000,000 |
| Prior year comparative | |
| Label | Six months ended June 30, 2025 |
| Period start | 2025-01-01 |
| Period end | 2025-06-30 |
| Period type | six months |
| Source accession | 0001628280-26-049493 |
| Income statement | |
| Net revenue | 19,441,000,000 |
| Cost of sales | 6,305,000,000 |
| Gross profit | 13,136,000,000 |
| Marketing administration and research costs | 5,416,000,000 |
| Impairment of goodwill | 41,000,000 |
| Corporate expenses and other | 423,000,000 |
| Operating income | 7,256,000,000 |
| Interest expense net | 518,000,000 |
| Pension and other employee benefit costs | 23,000,000 |
| Earnings before income taxes | 6,715,000,000 |
| Provision for income taxes | 1,311,000,000 |
| Impairment related to rbh equity investment | 0 |
| Equity investments and securities income loss net | -581,000,000 |
| Net earnings including noncontrolling interests | 5,985,000,000 |
| Net earnings attributable to noncontrolling interests | 256,000,000 |
| Net income attributable to shareholders | 5,729,000,000 |
| Net income available to common stockholders | 5,713,000,000 |
| Basic EPS | 3.67 |
| Diluted EPS | 3.67 |
| Basic shares | 1,556,000,000 |
| Diluted shares | 1,558,000,000 |
| Cash flow | |
| Operating cash flow | 3,062,000,000 |
| Capital expenditures | -760,000,000 |
| Investing cash flow | -2,750,000,000 |
| Dividends paid | -4,222,000,000 |
| Financing cash flow | -890,000,000 |
| Free cash flow | 2,302,000,000 |
| Supplemental | |
| Depreciation and amortization | 970,000,000 |
| Dividends declared per share | 2.7 |
| Excise taxes on products | 25,274,000,000 |
| Segments | |
| International smoke free | |
| Net revenues | 6,471,000,000 |
| Cost of sales | -2,066,000,000 |
| Gross profit | 4,405,000,000 |
| International combustibles | |
| Net revenues | 11,209,000,000 |
| Cost of sales | -3,774,000,000 |
| Gross profit | 7,435,000,000 |
| US | |
| Net revenues | 1,762,000,000 |
| Cost of sales | -466,000,000 |
| Gross profit | 1,296,000,000 |
| Net revenue by product category | |
| Total smoke free | 8,055,000,000 |
| Total combustible tobacco | 11,386,000,000 |
PM trailing twelve month income statement and cash flow
| Trailing twelve months ended June 30, 2026 | |
|---|---|
| Label | Trailing twelve months ended June 30, 2026 |
| Period start | 2025-07-01 |
| Period end | 2026-06-30 |
| Period type | trailing twelve months |
| Source accession | 0001628280-26-005939 and 0001628280-26-049493 |
| Derivation | Full year 2025 plus the six months ended June 30, 2026, less the six months ended June 30, 2025. |
| Income statement | |
| Net revenue | 42,545,000,000 |
| Cost of sales | 13,835,000,000 |
| Gross profit | 28,710,000,000 |
| Impairment of goodwill | 0 |
| Operating income | 16,059,000,000 |
| Interest expense net | 928,000,000 |
| Pension and other employee benefit costs | 13,000,000 |
| Earnings before income taxes | 15,118,000,000 |
| Provision for income taxes | 3,057,000,000 |
| Impairment related to rbh equity investment | 511,000,000 |
| Equity investments and securities income loss net | 120,000,000 |
| Net earnings including noncontrolling interests | 11,430,000,000 |
| Net earnings attributable to noncontrolling interests | 556,000,000 |
| Net income attributable to shareholders | 10,874,000,000 |
| Net income available to common stockholders | 10,844,000,000 |
| Diluted EPS | 6.95 |
| Cash flow | |
| Operating cash flow | 14,264,000,000 |
| Capital expenditures | -1,542,000,000 |
| Investing cash flow | -1,194,000,000 |
| Dividends paid | -9,006,000,000 |
| Financing cash flow | -11,121,000,000 |
| Free cash flow | 12,722,000,000 |
| Supplemental | |
| Depreciation and amortization | 2,049,000,000 |
| Excise taxes on products | 55,763,000,000 |
Adjustments
| Value | |
|---|---|
| Splits applied | none |
| Splits note | Philip Morris International has not split its stock in the period covered by these filings, so no per-share figure has been restated here. |
| ADR ratio | n/a |
| ADR note | Philip Morris International is a U.S. domestic filer and its common stock trades directly on the New York Stock Exchange, so no American depositary share conversion applies. |
| FX | None applied. Philip Morris International reports in U.S. dollars. |
Notes
- Every figure is stated in actual U.S. dollars, converted from the millions the filings print. Share counts are in actual shares and per-share amounts in dollars.
- The annual periods come from the consolidated financial statements in the Form 10-K for the year ended December 31, 2025 (accession 0001628280-26-005939). That filing prints the years ended December 31, 2025, 2024 and 2023 on its statements of earnings and cash flows, and balance sheets at December 31, 2025 and 2024 only. FY2023 therefore carries an income statement and a cash flow statement but no balance sheet.
- The quarterly and year-to-date figures come from the Form 10-Q for the quarter ended June 30, 2026 (accession 0001628280-26-049493). That filing prints a three-month statement of earnings and a separate six-month statement of earnings. The three-month columns are reported here as the June 2026 and June 2025 quarters; the six-month columns are held in the year-to-date block, with the prior-year six months stored alongside them.
- The 10-Q presents cash flows for the six-month period only, so no cash flow figures are reported for the June 2026 or June 2025 quarters.
- Effective January 1, 2026 Philip Morris International reorganized into three reportable segments - International Smoke-Free, International Combustibles and the U.S., which includes the Aspeya wellness unit - replacing the four geographic segments used previously, and adopted segment gross profit in place of regional operating income as its primary measure of segment profitability. At the same time it added a "Corporate expenses and other" caption to the statement of earnings, moving foreign currency gains and losses and restricted and performance share unit compensation expense out of cost of sales and out of marketing, administration and research costs. The 10-Q restates the 2025 interim comparatives on this basis. The 10-K, filed before the change, presents the annual years on the earlier basis. The company states that the reclassification did not change its financial position, results of operations or cash flows; net revenues, operating income and net earnings are identical on either basis.
- The trailing-twelve-month view adds the six months ended June 30, 2026 to full-year 2025 and subtracts the six months ended June 30, 2025. Its cost of sales and gross profit therefore combine the 10-K's presentation of 2025 with the current presentation of the 2026 interim periods. Recast schedules the company furnished on March 13, 2026 (accession 0001628280-26-017497) show the difference between the two presentations to be about $22 million of full-year 2025 cost of sales, which is immaterial against a trailing-twelve-month cost of sales of $13.8 billion. Marketing, administration and research costs are affected far more by the same reclassification and are deliberately left out of the trailing-twelve-month view.
- Cash flow lines are carried with the signs the statements print, so capital expenditures, dividends paid and net cash used in investing and financing activities are negative. Free cash flow is operating cash flow less capital expenditures.
- "Equity investments and securities (income)/loss, net" and "Pension and other employee benefit (income) costs" are presented in the statements of earnings as deductions in arriving at net earnings. A negative amount in those two lines is income, matching the parentheses the filing prints.
- Philip Morris International reports a stockholders' deficit rather than positive equity: total stockholders' deficit including noncontrolling interests was $8.0 billion at December 31, 2025 and $6.7 billion at June 30, 2026. That is what the balance sheet reports. It reflects the cumulative cost of repurchased stock and dividends exceeding earnings reinvested in the business, and the deficit has narrowed over the periods shown.
- Total debt is the sum of short-term borrowings, the current portion of long-term debt and long-term debt as those three lines appear on the balance sheet. The filings do not print a total debt line.
- Earnings per share is computed under the two-class method. "Net income available to common stockholders" here is the filing's "Net earnings for basic and diluted EPS", which is net earnings attributable to PMI less the distributed and undistributed earnings attributable to participating share-based payment awards. Both that figure and net earnings attributable to PMI are reported.
- Segment net revenues, cost of sales and gross profit are reported for the quarters and the year-to-date period only, on the three-segment structure adopted in 2026. The 10-K's annual segment disclosure uses the four geographic segments that structure replaced and is not comparable, so no annual segment data is carried here. Segment cost of sales is shown as a deduction in the filing's segment table and keeps that negative sign.
- Only figures reported under U.S. generally accepted accounting principles are used. The adjusted, currency-neutral and "operating companies income" measures that appear in the company's management discussion and in its earnings materials are non-GAAP and are not reported here.
- No balance sheet at June 30, 2025 appears in the 10-Q, which presents balance sheets at June 30, 2026 and December 31, 2025. The total stockholders' deficit and noncontrolling interests shown for the June 2025 quarter are taken from that filing's statement of stockholders' (deficit) equity, the only balance sheet information it gives for that date.
- The balance sheet at December 31, 2025 as printed in the 10-Q agrees line for line with the 10-K, so no prior-period balance sheet has been restated.
Uncertainties
- No cash flow figures are reported for the June 2026 or June 2025 quarters. The 10-Q reports cash flows for the six months only, and the first-quarter statement that would allow the quarter to be derived by difference is not part of this filing set.
- Trailing-twelve-month cost of sales and gross profit combine two presentations of the same lines, as described in the notes. The amounts are within roughly $22 million of a like-for-like basis but are not exactly comparable.
- Trailing-twelve-month diluted earnings per share of $6.95 is the reported full-year 2025 amount plus the reported six months of 2026 less the reported six months of 2025 ($7.26 + $3.36 - $3.67). It is an approximation, because the weighted-average share counts of the three periods differ slightly, and no trailing-twelve-month share count is reported.
- Total debt is a sum of three balance-sheet lines rather than a figure the company itself prints.
- FY2023 carries no balance sheet, and the June 2025 quarter carries only total equity and noncontrolling interests, because those are the only figures the filings present for those dates.
Company details
| Value | |
|---|---|
| Name | Philip Morris International Inc. |
| Ticker | PM |
| CIK | 0001413329 |
| Exchange | NYSE |
| State | Connecticut |
| Incorporation | Virginia |
| SIC | 2111 |
| Office | Manufacturing |
| Industry | Cigarettes |
Fiscal period
| FY2026 | |
|---|---|
| Fiscal year | 2026 |
| Fiscal period | Q2 |
| Tag | FY26Q2 |
| Period end | 2026-06-30 |
| Form | 10-Q |
| Accession | 0001628280-26-049493 |
| Fiscal year end | 1231 |
| Source | facts |
FAQ · Philip Morris International financial statements
How much revenue did Philip Morris International report in Q2 FY2026?
Philip Morris International reported $11.19 billion in net revenues for Q2 FY2026, the quarter ended June 30, 2026. That is up 10.4% from $10.14 billion in the same quarter a year earlier.
What was Philip Morris International's net income in Q2 FY2026?
Philip Morris International reported net income attributable to shareholders of $2.82 billion for Q2 FY2026, the quarter ended June 30, 2026, down 7.3% from $3.04 billion a year earlier.
Why did Philip Morris International's earnings per share fall in Q2 FY2026?
Philip Morris International posted diluted earnings per share of $1.80 in Q2 FY2026, down from $1.95 a year earlier, even as operating income rose to $4.53 billion. The decline came from items below the operating line: a non-cash impairment charge of $511 million against the company's equity investment in Rothmans, Benson & Hedges, lower income from equity security investments and a higher effective tax rate.
How much of Philip Morris International's revenue comes from smoke-free products?
Smoke-free products generated $4.64 billion of Philip Morris International's $11.19 billion in total net revenues in Q2 FY2026, up 11.6% from a year earlier. The balance came from combustible tobacco.
Where can I get Philip Morris International Inc. (PM) financial data in machine-readable form?
Ticker Scout publishes Philip Morris International Inc.'s financial statements as JSON at https://tickerscout.ai/pm/financials.json, free, with no API key and no signup. The 10-K and 10-Q narrative and the 8-K events digest are published as Markdown at https://tickerscout.ai/pm/narrative.md and https://tickerscout.ai/pm/events.md. Philip Morris International Inc.'s SEC CIK is 0001413329. Every figure cites the SEC accession number it came from, so it can be checked against sec.gov.
When does Philip Morris International Inc. (PM) next file with the SEC?
Philip Morris International Inc. (PM) is expected to file its next Form 10-Q with the SEC on or around October 22, 2026. That date is a projection rather than a company-announced date: it is derived from Philip Morris International Inc.'s own filing history with the SEC, by taking the date the company filed the same fiscal period a year earlier and adding 52 weeks. The most recent periodic report on file is the 10-Q for Q2 FY2026, the period ended 2026-06-30, SEC accession 0001628280-26-049493.
Related companies
How this page was built
This page was built from three of Philip Morris International Inc.'s own filings with the SEC, read one at a time. Nothing on it is taken from a pre-tagged dataset, a data vendor or another website. The figures are on the company's own fiscal calendar and in actual dollars, as the filings report them. Where the filings do not support a figure, the record says so instead of reporting a zero; this period names five such gaps.
A single company files thousands of pages with the SEC in a year, and no two companies file them the same way, so the reading and the assembly here are done by AI rather than by rules that break on the differences. Every pass is then audited back against the filings it came from before the page is published, and anything the filings do not support is left out and named rather than filled in. AI can still make mistakes. That is why the accession numbers are printed: the filing is the authority, and this page is a route to it.
Published by Ticker Scout, an independent publisher of company filings data. About Ticker Scout · Disclaimer
Built from Philip Morris International Inc.'s SEC filings by Ticker Scout; accession numbers are cited throughout so every figure can be checked against sec.gov. Free to cite with attribution: Ticker Scout (tickerscout.ai). Not investment advice, see the Disclaimer.